297. Enhertu, Xeloda, and Living with De Novo Metastatic Breast Cancer: Annick’s Story
Published: May 18, 2026
Duration: 40:25
Love the podcast? Send us a text!
In this episode of Breast Cancer Conversations, host Laura Carfang speaks with Annick Pyfferoen about her experience being diagnosed with de novo metastatic breast cancer and navigating several lines of treatment including targeted therapy, chemotherapy, a clinical trial attempt involving tumor-infiltrating lymphocytes, Enhertu, and Xeloda.
She speaks openly about what it felt like to experience rapid progression and why having a plan, even one that may change, helps her navigate uncertainty.
This episode is a reminder that metastatic breast cancer care is not only about what i...